Bioscience and pharmaceutical
Economic Development
Insider Only
New Castle County
News
Public Companies
Prelude Therapeutics to raise $100M in share sale
Share
WILMINGTON – Prelude Therapeutics, the clinical-stage precision oncology company, announced Thursday that it’s selling millions of new shares in the publicly traded company to raise $100 million to support its drug pipeline. The sale marks the first major capital infusion in two years for Prelude, which is currently based at the DuPont Experimental Station but
Want to Read More?
Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.
Already an Insider? Log In.